Hualei Bu

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer

Jiangdong Xiang, Rongjian Su, Chengwen Jin, 2022, Frontiers in Oncology.

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer

Jiangdong Xiang, Rongjian Su, Chengwen Jin, 2021, Frontiers in Oncology.

FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.

Zhaojian Liu, B. Kong, Hongfeng Yu, 2018, International journal of oncology.

Effects of neoadjuvant chemotherapy in ovarian cancer patients with different germline BRCA1/2 mutational status: A retrospective study

Mengdi Fu, B. Kong, Jingying Chen, 2021 .

Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study

B. Kong, Mengdi Fu, Jin Peng, 2022, Frontiers in Oncology.